Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications

dc.contributor.authorRodríguez Barrios, José Manuel
dc.contributor.authorPérez Alcántara, Ferran
dc.contributor.authorCrespo Palomo, Carlos
dc.contributor.authorGonzález García, Paloma
dc.contributor.authorAntón de las Heras, Enrique
dc.contributor.authorBrosa, Max
dc.date.accessioned2013-07-10T11:48:01Z
dc.date.available2013-07-10T11:48:01Z
dc.date.issued2012-12
dc.date.updated2013-07-10T11:48:01Z
dc.description.abstractThe objective of this study was to evaluate the methodological characteristics of cost-effectiveness evaluations carried out in Spain, since 1990, which include LYG as an outcome to measure the incremental cost-effectiveness ratio. METHODS: A systematic review of published studies was conducted describing their characteristics and methodological quality. We analyse the cost per LYG results in relation with a commonly accepted Spanish cost-effectiveness threshold and the possible relation with the cost per quality adjusted life year (QALY) gained when they both were calculated for the same economic evaluation. RESULTS: A total of 62 economic evaluations fulfilled the selection criteria, 24 of them including the cost per QALY gained result as well. The methodological quality of the studies was good (55%) or very good (26%). A total of 124 cost per LYG results were obtained with a mean ratio of 49,529<euro> and a median of 11,490<euro> (standard deviation of 183,080). Since 2003, a commonly accepted Spanish threshold has been referenced by 66% of studies. A significant correlation was found between the cost per LYG and cost per QALY gained results (0.89 Spearman-Rho, 0.91 Pearson). CONCLUSIONS: There is an increasing interest for economic health care evaluations in Spain, and the quality of the studies is also improving. Although a commonly accepted threshold exists, further information is needed for decision-making as well as to identify the relationship between the costs per LYG and per QALY gained.
dc.format.extent44 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec613543
dc.identifier.issn1618-7598
dc.identifier.urihttps://hdl.handle.net/2445/44707
dc.language.isoeng
dc.publisherSpringer Verlag
dc.relation.isformatofVersió postprint del document publicat a: http://dx.doi.org/10.1007/s10198-011-0326-y
dc.relation.ispartofEuropean Journal of Health Economics, 2012, vol. 13, num. 6, p. 723-740
dc.relation.urihttp://dx.doi.org/10.1007/s10198-011-0326-y
dc.rights(c) Springer Verlag, 2012
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject.classificationAnàlisi econòmica
dc.subject.classificationEconomia de la salut
dc.subject.classificationEspanya
dc.subject.otherEconomic analysis
dc.subject.otherMedical economics
dc.subject.otherSpain
dc.titleThe use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
613543.pdf
Mida:
906.1 KB
Format:
Adobe Portable Document Format